Viewing Study NCT06625359


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-01-31 @ 11:33 PM
Study NCT ID: NCT06625359
Status: TERMINATED
Last Update Posted: 2024-10-03
First Post: 2024-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma
Sponsor: Seoul National University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Central Nervous System Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PCNSL View
None SCNSL View
None high-dose chemotherapy followed by autoSCT View
None Thiotepa, Busulfan, Cyclophosphamide View